The HER2/neu (c-erbB-2) proto-oncogene is a transmembrane receptor tyrosine kinase that is clinically indicated in a number of carcinomas. Overexpression of the c-erbB-2 protein has been associated with ductal breast cancer, as well as pulmonary and gastric adenocarcinomas. A correlation between HER2 and p53 has also been documented, as overexpression of both proteins has been associated with early invasion and metastasis in bladder cancer.

• IHC012-Her2 Datasheet-RUO

• MSDS
• 2021 NordiQC Assessment Report for IHC012: Good
• 2022 NordiQC Assessment Report for IHC012: Good

CLONE:
IHC012

ISOTYPE:
IgG

HOST SPECIES:
Rabbit

CLONALITY:
Monoclonal

POSITIVE CONTROL:
Breast Carcinoma

DILUTION RANGE:


INTENDED USE/REG. STATUS:
RUO

ADDITIONAL INFORMATION:
NordiQC Rating: Good (Assessment Run B32 2021 and Run B33 2022)